Who Buys Dextromethorphan from India — 387 Importers Behind a $14.9M Market
India's dextromethorphan import market is served by 387 active buyers who collectively imported $14.9M across 1,322 shipments. BONAPHARM S.A.C.... (PERU) leads with a 5.8% market share, followed by PRODOSE INC. and SPIRIT PHARMACEUTICALS LLC. The top 5 buyers together control 19.4% of total import value, reflecting a moderately competitive buyer landscape.
Top Dextromethorphan Importers — Ranked by Import Value
BONAPHARM S.A.C.... (PERU) is the leading dextromethorphan importer from India, holding a 5.8% share of the $14.9M market across 1,322 shipments from 387 buyers. The top 5 buyers — BONAPHARM S.A.C.... (PERU), PRODOSE INC. (UNITED STATES), SPIRIT PHARMACEUTICALS LLC (UNITED STATES), BONAPHARM S A C (PERU), SUNSHINE HEALTHCARE LANKA LTD (SRI LANKA) — collectively control 19.4% of total import value.
Top Dextromethorphan Buyers & Importers
Ranked by import value · 387 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | BONAPHARM S.A.C....PERU GRIPACHECK CAPSULES 25X4`S | $861.7K | 5 | 5.8% |
| 2 | PRODOSE INC.UNITED STATES GUAIFENESIN & DEXTROMETHORPHAN HBR EXTENDEXTROMETHORPHAN HYDROBROMIDE CAPSULE 15MG 904 ANNEXURE A | $559.6K | 5 | 3.8% |
| 3 | SPIRIT PHARMACEUTICALS LLCUNITED STATES GUAIFENESIN & DEXTROMETHORPHAN HBR EXTENDEXTROMETHORPHAN HYDROBROMIDE CAPSULE 15MG 904 ANNEXURE A | $534.8K | 5 | 3.6% |
| 4 | BONAPHARM S A CPERU GRIPACHECK CAPSULES 25X4`S | $506.7K | 5 | 3.4% |
| 5 | SUNSHINE HEALTHCARE LANKA LTDSRI LANKA | $413.4K | 5 | 2.8% |
| 6 | SHIELD PHARMACEUTICALS CORP.UNITED STATES GUAIFENESIN & DEXTROMETHORPHAN HBR EXTENDEXTROMETHORPHAN HYDROBROMIDE CAPSULE 15MG 904 ANNEXURE A | $298.5K | 5 | 2.0% |
| 7 | SPIRIT PHARMACEUTICALSUNITED STATES GUAIFENESIN & DEXTROMETHORPHAN HBR EXTENDEXTROMETHORPHAN HYDROBROMIDE CAPSULE 15MG 904 ANNEXURE A | $285.9K | 5 | 1.9% |
| 8 | CAFERMA S.A.C.PERU GRIPACHECK CAPSULES 25X4`S | $278.6K | 5 | 1.9% |
| 9 | BALMED PHARMA PRIVATE LIMITEDNEPAL | $272.6K | 5 | 1.8% |
| 10 | PANBIO PHARM LLCRUSSIA | $269.0K | 5 | 1.8% |
| 11 | PLANET PHARMAFRANCE | $234.2K | 5 | 1.6% |
| 12 | HEALTHLIFE OF USA LLCUNITED STATES GUAIFENESIN & DEXTROMETHORPHAN HBR EXTENDEXTROMETHORPHAN HYDROBROMIDE CAPSULE 15MG 904 ANNEXURE A | $233.0K | 5 | 1.6% |
| 13 | REED - LANE INCUNITED STATES GUAIFENESIN & DEXTROMETHORPHAN HBR EXTENDEXTROMETHORPHAN HYDROBROMIDE CAPSULE 15MG 904 ANNEXURE A | $228.2K | 5 | 1.5% |
| 14 | XXROHXXLTHXXLCUNITED STATES GUAIFENESIN & DEXTROMETHORPHAN HBR EXTENDEXTROMETHORPHAN HYDROBROMIDE CAPSULE 15MG 904 ANNEXURE A | $207.0K | 5 | 1.4% |
| 15 | OHM LABORATORIES INC.UNITED STATES GUAIFENESIN & DEXTROMETHORPHAN HBR EXTENDEXTROMETHORPHAN HYDROBROMIDE CAPSULE 15MG 904 ANNEXURE A | $176.0K | 5 | 1.2% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Dextromethorphan — and from which countries?
Flow of Dextromethorphan exports from India: each country's share and the named importers behind the numbers
Dextromethorphan — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $3.9M through 73 shipments. This represents a market share of 26.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• PRODOSE INC. - $559.6K (14.3% of country's total business)
• SPIRIT PHARMACEUTICALS LLC - $534.8K (13.7% of country's total business)
• SHIELD PHARMACEUTICALS CORP. - $298.5K (7.6% of country's total business)
• SPIRIT PHARMACEUTICALS - $285.9K (7.3% of country's total business)
• HEALTHLIFE OF USA LLC - $233.0K (6.0% of country's total business)
• Rest of United States's importers - $2.0M (51.0% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $53.5K, indicating premium pricing strategy compared to the market average of $11.2K.
United States is a key market for Dextromethorphan imports, representing 26.3% of total trade value.
2Peru
Peru emerges as the second largest importing country, achieving a total trade value of $1.7M through 34 shipments. This represents a market share of 11.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Peru has a diverse importer base, with their top importers including:
• BONAPHARM S.A.C.... - $861.7K (51.2% of country's total business)
• BONAPHARM S A C - $506.7K (30.1% of country's total business)
• CAFERMA S.A.C. - $278.6K (16.5% of country's total business)
Key Insight: Peru demonstrates strong market positioning with an average shipment value of $49.5K, indicating premium pricing strategy compared to the market average of $11.2K.
Peru is a key market for Dextromethorphan imports, representing 11.3% of total trade value.
3Myanmar
Myanmar emerges as the third largest importing country, achieving a total trade value of $1.0M through 0 shipments. This represents a market share of 7.0% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Myanmar demonstrates strong market positioning with an average shipment value of $1.0M, indicating premium pricing strategy compared to the market average of $11.2K.
Myanmar is a key market for Dextromethorphan imports, representing 7.0% of total trade value.
4Belgium
Belgium emerges as the fourth largest importing country, achieving a total trade value of $538.1K through 0 shipments. This represents a market share of 3.6% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $538.1K, indicating premium pricing strategy compared to the market average of $11.2K.
Belgium is a key market for Dextromethorphan imports, representing 3.6% of total trade value.
5Sri Lanka
Sri Lanka emerges as the fifth largest importing country, achieving a total trade value of $499.9K through 9 shipments. This represents a market share of 3.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Sri Lanka has a diverse importer base, with their top importers including:
• SUNSHINE HEALTHCARE LANKA LTD - $413.4K (82.7% of country's total business)
Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $55.5K, indicating premium pricing strategy compared to the market average of $11.2K.
Sri Lanka is a key market for Dextromethorphan imports, representing 3.4% of total trade value.
Buyer Segment Analysis
TransData Nexus Dextromethorphan buyer market intelligence
1Buyer Segment Analysis
The importation of Dextromethorphan from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like BONAPHARM S.A.C. (Peru) and PRODOSE INC. (United States) function as intermediaries, procuring large quantities to supply to pharmacies and healthcare providers. Their purchasing patterns are characterized by bulk orders to meet consistent market demand.
- Contract Manufacturers: Companies such as SPIRIT PHARMACEUTICALS LLC (United States) and SHIELD PHARMACEUTICALS CORP. (United States) import Dextromethorphan as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement is aligned with production schedules and client requirements, leading to periodic, large-volume purchases.
- Re-exporters: Entities like PANBIO PHARM LLC (Russia) may import Dextromethorphan for re-export to neighboring markets, leveraging regional trade agreements. Their buying behavior is influenced by external market demands and regulatory environments, resulting in variable order sizes and frequencies.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Dextromethorphan buyer market intelligence
1Country-Specific Import Regulations
United States
1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must register with the FDA and ensure that Dextromethorphan products comply with the Federal Food, Drug, and Cosmetic Act. This includes facility registration, product listing, and adherence to Current Good Manufacturing Practices (CGMP).
3. Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and FDA review times.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.
Peru
1. Drug Regulatory Authority: Dirección General de Medicamentos, Insumos y Drogas (DIGEMID).
2. Import Registration Process: Importers must obtain a sanitary registration from DIGEMID, which involves submitting technical documentation, including quality, safety, and efficacy data.
3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, subject to the completeness of the dossier and regulatory review.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 6% import duty in Peru.
Myanmar
1. Drug Regulatory Authority: Food and Drug Administration, Ministry of Health and Sports.
2. Import Registration Process: Importers are required to obtain a product registration certificate, which includes submitting samples, product information, and manufacturing details.
3. Estimated Timeline for Registration: The process can take approximately 6 to 9 months, depending on the regulatory workload and completeness of the submission.
4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally exempt from import duties in Myanmar.
Belgium
1. Drug Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
2. Import Registration Process: Importers must hold a wholesale distribution authorization and ensure that products are registered in the European Union, complying with EU directives and regulations.
3. Estimated Timeline for Registration: The registration process can take 12 to 18 months, depending on the complexity of the product and regulatory assessments.
4. Import Tariff/Duty for HS 30049099: As part of the EU, Belgium applies a 0% import duty on pharmaceutical products under this HS code.
Sri Lanka
1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).
2. Import Registration Process: Importers must obtain a registration certificate from NMRA, which involves submitting detailed product information, including quality, safety, and efficacy data.
3. Estimated Timeline for Registration: The registration process typically takes 9 to 12 months, subject to regulatory review and completeness of the application.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 0% import duty in Sri Lanka.
Demand Drivers & Market Opportunity
TransData Nexus Dextromethorphan buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Dextromethorphan in importing countries is driven by several factors:
- Disease Prevalence: Dextromethorphan is widely used as a cough suppressant in the treatment of respiratory conditions such as the common cold and bronchitis. High incidence rates of these conditions, especially during seasonal changes, contribute to consistent demand.
- Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For instance, the inclusion of Dextromethorphan in national formularies ensures its availability in public health facilities.
- Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines, including Dextromethorphan, to meet the needs of the population.
- WHO Essential Medicines List Procurement: Dextromethorphan's inclusion in the WHO Model List of Essential Medicines encourages its procurement by member states, ensuring its availability for treating cough-related conditions.
- Tender-Based Purchasing: Government and international health organizations often procure medicines through tender processes, leading to bulk purchases of Dextromethorphan to supply public health programs.
With 387 buyers across 94 countries, the market for Dextromethorphan presents significant opportunities for suppliers, especially in regions with high respiratory disease prevalence and robust public health initiatives.
Common Questions — Dextromethorphan Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest dextromethorphan buyer importing from India?
Based on import volume and value, BONAPHARM S.A.C.... (PERU) leads with $861.7K in imports and a 5.8% market share — the highest of any single dextromethorphan importer. PRODOSE INC. (UNITED STATES) and SPIRIT PHARMACEUTICALS LLC (UNITED STATES) are the next largest buyers.
QHow many companies buy dextromethorphan from India?
There are 387 active dextromethorphan buyers importing from India, with a combined market of $14.9M across 1,322 shipments to 94 countries. The top 5 buyers hold 19.4% of total import value, while the remaining 382 buyers handle the other 80.6%.
QWhich countries import the most dextromethorphan from India?
The top importing countries for dextromethorphan from India are United States (26.3%), Peru (11.3%), Myanmar (7.0%), Belgium (3.6%), Sri Lanka (3.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of dextromethorphan, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for dextromethorphan from India?
The average import transaction value for dextromethorphan from India is $11.2K, with an average unit price of $7.72 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Dextromethorphan buyer market intelligence
1Buyer Segment Analysis
The importation of Dextromethorphan from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like BONAPHARM S.A.C. (Peru) and PRODOSE INC. (United States) function as intermediaries, procuring large quantities to supply to pharmacies and healthcare providers. Their purchasing patterns are characterized by bulk orders to meet consistent market demand.
- Contract Manufacturers: Companies such as SPIRIT PHARMACEUTICALS LLC (United States) and SHIELD PHARMACEUTICALS CORP. (United States) import Dextromethorphan as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement is aligned with production schedules and client requirements, leading to periodic, large-volume purchases.
- Re-exporters: Entities like PANBIO PHARM LLC (Russia) may import Dextromethorphan for re-export to neighboring markets, leveraging regional trade agreements. Their buying behavior is influenced by external market demands and regulatory environments, resulting in variable order sizes and frequencies.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Dextromethorphan buyer market intelligence
1Country-Specific Import Regulations
United States
1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must register with the FDA and ensure that Dextromethorphan products comply with the Federal Food, Drug, and Cosmetic Act. This includes facility registration, product listing, and adherence to Current Good Manufacturing Practices (CGMP).
3. Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and FDA review times.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.
Peru
1. Drug Regulatory Authority: Dirección General de Medicamentos, Insumos y Drogas (DIGEMID).
2. Import Registration Process: Importers must obtain a sanitary registration from DIGEMID, which involves submitting technical documentation, including quality, safety, and efficacy data.
3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, subject to the completeness of the dossier and regulatory review.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 6% import duty in Peru.
Myanmar
1. Drug Regulatory Authority: Food and Drug Administration, Ministry of Health and Sports.
2. Import Registration Process: Importers are required to obtain a product registration certificate, which includes submitting samples, product information, and manufacturing details.
3. Estimated Timeline for Registration: The process can take approximately 6 to 9 months, depending on the regulatory workload and completeness of the submission.
4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally exempt from import duties in Myanmar.
Belgium
1. Drug Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
2. Import Registration Process: Importers must hold a wholesale distribution authorization and ensure that products are registered in the European Union, complying with EU directives and regulations.
3. Estimated Timeline for Registration: The registration process can take 12 to 18 months, depending on the complexity of the product and regulatory assessments.
4. Import Tariff/Duty for HS 30049099: As part of the EU, Belgium applies a 0% import duty on pharmaceutical products under this HS code.
Sri Lanka
1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).
2. Import Registration Process: Importers must obtain a registration certificate from NMRA, which involves submitting detailed product information, including quality, safety, and efficacy data.
3. Estimated Timeline for Registration: The registration process typically takes 9 to 12 months, subject to regulatory review and completeness of the application.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 0% import duty in Sri Lanka.
Demand Drivers & Market Opportunity
TransData Nexus Dextromethorphan buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Dextromethorphan in importing countries is driven by several factors:
- Disease Prevalence: Dextromethorphan is widely used as a cough suppressant in the treatment of respiratory conditions such as the common cold and bronchitis. High incidence rates of these conditions, especially during seasonal changes, contribute to consistent demand.
- Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For instance, the inclusion of Dextromethorphan in national formularies ensures its availability in public health facilities.
- Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines, including Dextromethorphan, to meet the needs of the population.
- WHO Essential Medicines List Procurement: Dextromethorphan's inclusion in the WHO Model List of Essential Medicines encourages its procurement by member states, ensuring its availability for treating cough-related conditions.
- Tender-Based Purchasing: Government and international health organizations often procure medicines through tender processes, leading to bulk purchases of Dextromethorphan to supply public health programs.
With 387 buyers across 94 countries, the market for Dextromethorphan presents significant opportunities for suppliers, especially in regions with high respiratory disease prevalence and robust public health initiatives.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 387 global importers of Dextromethorphan identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 1,322 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 94 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,322 Verified Shipments
387 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists